@article{ref1,
title="Donepezil in the treatment of mild to moderate Alzheimer's disease: Report of a Belgian multicenter study",
journal="Acta neurologica Belgica",
year="2003",
author="Santens, P. and Ventura, M.",
volume="103",
number="3",
pages="159-163",
abstract="In this report the results of a Belgian multicenter 24-week open-label study with donepezil in the treatment of mild to moderate Alzheimer's disease are described. Efficacy and safety were evaluated in a sample of 200 patients recruited in 25 Belgian centers. No significant changes could be found in cognition and behaviour over this 6-month period. Changes in daily functioning were small. Safety data were comparable to those reported in international trials. These results suggest that the findings of more robust double-blind, placebo-controlled studies can be confirmed in real life situations.<p /><p>Language: en</p>",
language="en",
issn="0300-9009",
doi="",
url="http://dx.doi.org/"
}